Dr. Jackman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3468Fax+1 617-632-5786
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2006
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
- The Warren Alpert Medical School of Brown UniversityClass of 2000
Certifications & Licensure
- FL State Medical License 2023 - Present
- ME State Medical License Current
- NH State Medical License 2009 - 2026
- RI State Medical License 2023 - 2026
- VT State Medical License 2023 - 2026
- CT State Medical License 2023 - 2025
- MA State Medical License 2004 - 2025
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC Start of enrollment: 2010 Feb 01
- Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants Start of enrollment: 2013 Dec 12
- Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma Start of enrollment: 2016 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 121 citationsDefinitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung CancerRavi B. Parikh, Angel M. Cronin, David Kozono, Geoffrey R. Oxnard, Raymond H. Mak
International Journal of Radiation Oncology, Biology, Physics. 2014-07-15 - 78 citationsErlotinib plus bevacizumab in previously treated patients with malignant pleural mesotheliomaDavid M. Jackman, Hedy L. Kindler, Beow Y. Yeap, Panos Fidias, Ravi Salgia
Cancer. 2008-08-15 - 375 citationsLung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Douglas E. Wood, Ella A. Kazerooni, Scott Baum, Georgie A. Eapen, David S. Ettinger
Journal of the National Comprehensive Cancer Network. 2018-04-01
Press Mentions
- Cancer Without Chemotherapy: ‘A Totally Different World’September 27th, 2021
- What Mesothelioma Awareness Day Means to a SurvivorSeptember 26th, 2019
- Royal Philips : Philips IntelliSpace Precision Medicine Oncology Pathways Powered by Dana-Farber Is Now LiveSeptember 11th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: